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Abstract
Background: Ideally clinical trials should use some form of randomization for allocating participants to the treatment
groups under trial. As an integral part of the process of assessing the eﬀectiveness of these treatment groups,
randomization performed well can reduce, if not eliminate, some forms of bias that can be evident in
non-randomized trials. Given the vast set of possible randomization methods to choose from we demonstrate a
method that incorporates many of the advantages of these other methods.
Methods: A step-by-step introduction of how to use the adaptive randomization algorithm for conducting a clinical
trial is given.
Results: The implications, eﬀects and capabilities of using the adaptive randomization algorithm are fully
demonstrated and explained using simulated data and examples from actual trials.
Conclusions: This paper provides an introduction to a dynamic type of treatment allocation, which fulﬁlls the
CONSORT requirements of participants being randomly allocated whilst maintaining a level of control of the balances
overall, within the stratiﬁcation variables and within the strata simultaneously. Maintaining control of the imbalances
within the groups is vital particularly if interim analyses are planned.
Trial registration: Current controlled trials ISRCTN17551624, ISRCTN37558856, ISRCTN97185214.
Background
The CONSORT statement says that: ‘Ideally, participants
should be assigned to comparison groups in the trial on
the basis of a chance (random) process characterized by
unpredictability’ [1]. There are many treatment allocation
methods available in the literature to achieve this. These
vary from simple randomization through to deterministic
methods, with other methods showing varying degrees of
control of the randomization process [2].
Deterministic methods obviously do not fulﬁll the
requirements denoted in the CONSORT statement and
are not now recommended. Simple randomization may be
the obvious method to ensure complete randomness of
allocations. However, a drawback is that balance within
treatment groups cannot be controlled and so imbalance
of treatment allocation can occur. Imbalances can cause
greater problems in smaller trials (<100 participants) than
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for larger trials; however, an imbalance of allocated treat-
ments within certain subgroups of the sample can still
cause problems within larger trials. Allocation methods to
overcome this problem have been developed. Thesemeth-
ods exert some control of the randomization process while
maintaining unpredictability. Many trials recruit partici-
pants sequentially and therefore the issue of maintaining
unpredictability whilst retaining a level of control can
become more diﬃcult.
Stratiﬁcation variables are variables chosen because it
is believed they have an eﬀect on the eﬃcacy of the
treatment under scrutiny. For example, gender could be
treated as a stratiﬁcation variable, to ensure that there
was a balance of genders between the treatment groups. It
would not be good if say all male participants were allo-
cated to one treatment group. If there is more than one
stratiﬁcation variable then their combination needs to be
considered in assessing the balance in treatment alloca-
tion. With two binary stratiﬁcation variables, for instance,
gender and age (<40, ≥40), then there are four strata, one
of these being male and<40. If only a few members of the
© 2013 Hoare et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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population are sampled in one of these four strata, then it
is likely that an imbalance will occur within this stratum.
The method we present here maintains unpredictability
during sequential participant recruitment while simulta-
neously allowing control over the balance across treat-
ment groups, within stratiﬁcation levels and within strata
[3]. Exerting control of the imbalance at themultiple levels
of the randomization process simultaneously has not been
proposed previously. We think that achieving this with a
simple function is the major advantage of this method.
The method has several advantages. It can accommo-
date two or more treatment groups. It utilizes a dynamic
method of calculating allocation probabilities. That is, the
probability of allocation to each treatment group is recal-
culated for every participant based on the participants
already allocated. It can accommodate as many discrete
leveled stratiﬁcation variables as desired. It controls bal-
ance at the overall level, within stratiﬁcation variables and
within strata, as well as being controlled sequentially. This
means that the group balance is kept in check through-
out the recruitment and randomization process making
interim analyses easily possible. It measures the imbal-
ance at the overall level, at the stratiﬁcation variable level
and at the stratum level, and uses a simple weighted sum
of squared diﬀerences to combine the imbalances at each
level.
Methods
The idea and design of the method
Figure 1 demonstrates the ideas behind how the partic-
ipants are allocated. Each time a new participant needs
to be randomized to the trial then the boundaries (rep-
resented by ‡) between the groups are recalculated. This
recalculation takes into account: (a) the number of people
already assigned to the treatment groups; (b) the number
of people within the relevant stratiﬁcation level and (c) the
number of people within the relevant stratum. The posi-
tion of the boundaries is adjusted accordingly. Once the
boundaries have been calculated, a number between 0 and
Figure 1 Probability boundaries for a two group randomization.
First group is a 1:1 allocation to either group at a point where there
are equal numbers in each group. The second is an example of a 1:3
allocation in favour of group B.
1 is randomly generated and the participant is assigned to
the group in which the generated number falls.
Weights (or parameters) are attached to each level of
the allocation under consideration (that is overall, strati-
ﬁcation level and stratum level) to control how much an
imbalance aﬀects the movement of the boundary. With
larger weights the movements of the proabbility bound-
aries are more pronounced. If balance at a particular
level is considered important then larger weights may be
assigned.
This paper explains the method by introducing the base
model, a worked example of the method, a selection of
simulations to demonstrate the eﬀect of the weights on the
algorithm and some examples from recent clinical trials.
The base method
The method for calculating the boundary between two
treatment groups is now given. These four steps form the
basis of all randomization set-ups for two or more groups:
1. Calculate the allocation odds, AB . This is related to the
allocation ratio deﬁned as A:B, that is the number
assigned to A in relation to B. For example, if the
intended allocation ratio is 1:1 then the allocation
odds are 11 = 1 and if the intended allocation ratio is
2:1 in favor of A then the allocation odds are 21 = 2.
2. Calculate the diﬀerence as:
dlevel =
√
Allocation odds × Total inB − Total inA√
Allocation odds
at each relevant level (overall, within stratiﬁcation
variable and within strata).
3. Calculate a weighted sum of squared signed
diﬀerences from Step 2. Take the diﬀerences from
Step 2, square them, multiply the squared diﬀerences
by their signs, (0 if the diﬀerence was zero, −1 if the
diﬀerence was negative and 1 if the diﬀerence was
positive), then multiply these squared signed
diﬀerences by their relevant weights. Finally add
them all up to give a total measure of imbalance.
4. Take the logit of this weighted sum to give the
probability of treatment A being assigned. The logit
function is:
Allocation odds × exp(a)
1 + Allocation odds × exp(a)
where exp(a) is the exponential of the number a.
Basemethod example (two-group randomization)
Take a trial with two treatment groups A and B, with an
allocation ratio of 2:1.We shall take two stratiﬁcation vari-
ables: gender (male and female) and center (X, Y and Z).
Let the ﬁrst participant who requires randomization be
female and from center Y. Take the weights to be 0.5 for
stratum, 0.2 for center and gender and 0.1 for total.
Hoare et al. Trials 2013, 14:19 Page 3 of 8
http://www.trialsjournal.com/content/14/1/19
1. The allocation ratio A:B is 2:1 therefore the
allocation odds are 21 = 2.
2. Calculate the diﬀerence at each relevant level:




2 × 0 − 0√
2
= 0
(b) At the center level (center Y) we currently
have no participants assigned giving:
dcenter =
√
2 × 0 − 0√
2
= 0
(c) At the gender level (female) we currently
have no participants assigned giving:
dgender =
√
2 × 0 − 0√
2
= 0
(d) At the stratum (female, center Y) level we




2 × 0 − 0√
2
= 0
3. Take the weighted sum of the signed diﬀerences.
This is:
0.1×02×0+0.2×02×0+0.2×02×0+0.5×02×0 = 0
4. Take the logit function of this weighted diﬀerence.
The probability of assigning the participant to
treatment A is:
2 × exp(0)
1 + 2 × exp(0) =
2
3
This is the expected result because for the ﬁrst alloca-
tion the participant should have twice as much chance of
being assigned to treatment A than to treatment B. A ran-
dom number between 0 and 1 is generated. If the random
number is less than 23 the participant is assigned to treat-
ment A, else the participant is assigned to treatment B.
Consider now that 12 participants have been random-
ized into the trial as shown in Table 1. If the 13th partici-
pant to enter the trial was female and from center Z then
the probability boundary would be calculated as:
1. As before the allocation ratio is 2:1 therefore the
allocation odds are 2.
2. Calculate the diﬀerence at each relevant level:
(a) At the overall level we currently have eight
participants in treatment A and four in
treatment B already assigned giving:
dtotal =
√
2 × 4 − 8√
2
= 0
Table 1 12 allocated participants in the basemethod
example
Gender Center Treatment A Treatment B
M X 1 0
F X 1 1
M Y 2 1
F Y 1 1
M Z 1 1
F Z 2 0
Totals 8 4
(Using a calculator may not give the exact
answer of zero.)
(b) At the center level (center Z) we currently
have three participants in treatment A and
one in treatment B giving:
dcenter =
√




(c) At the gender level (female) we currently
have four participants assigned to treatment
A and two assigned to treatment B giving:
dgender =
√
2 × 2 − 4√
2
= 0
(d) At the stratum (female, center Z) level we
currently have two participants assigned to








3. Take the weighted sum of the signed diﬀerences.
This is:









× −1 = −1.1
4. Take the logit function of this weighted diﬀerence.
The probability of assigning the participant to
treatment A:
2 × exp(−1.1)
1 + 2 × exp(−1.1) = 0.40
This indicates that the probability of assigning partic-
ipant 13 to treatment A is 0.4 and the probability of
assigning them to treatment B is 0.6. That means that
the boundary has shifted slightly in favor of assigning to
treatment B. Overall we can see that the assignments are
balanced in the required 2:1 ratio (8:4) and also balanced
within gender (4:2); however, within the current relevant
Hoare et al. Trials 2013, 14:19 Page 4 of 8
http://www.trialsjournal.com/content/14/1/19
stratum (center Z and female) there is a current assign-
ment of 2:0 and for center Z there is a current assignment
of 3:1, in both cases too many are allocated to A. These
imbalances result in the higher likelihood of assigning the
13th participant to treatment B.
Algorithmweighting
The weights chosen for use in Step 3 of the base equations
determine how important an imbalance at the relevant
level is. The bigger the weight used the more an imbal-
ance will be corrected. Generally, the method would be
weighted so that stratum has the largest weight, then
the stratiﬁcation variables with middle weight, then the
overall weighting having the smallest weight. This is
because the number of participants in the stratum (male,
center X) would be less than the number of partici-
pants in either stratiﬁcation variable (center or gender)
and both of these will be less than the number of par-
ticipants in the whole of the trial. Imbalances in the
smaller numbers have the greater impact and there-
fore need greater control necessitating the use of larger
weights.
Take the ﬁrst example of the two-group randomization
with allocation ratio 2:1. The weights used were 0.5 for the
stratum, 0.2 for both the stratiﬁcation variables and 0.1 for
overall. At Step 3 this gave us a weighted imbalance sum
of −1.1 giving the probability of assigning to treatment A
as 0.40.
If the weights are strengthened on this imbalance to 5
for the stratum, 2 for both the stratiﬁcation variables and
1 for overall, we get a weighted imbalance of:









× −1 = −11
Taking the logit function of this weighted diﬀerence, the
probability of assigning the participant to treatment A:
2 × exp(−11)
1 + 2 × exp(−11) = 0.0000167
The weights here are extreme, the likelihood of now
assigning to treatment A is very small. Weights of this
strength would not generally be used for a sequential
randomization but are used here to illustrate the point
that when the weights are increased the imbalance is
given more importance and assignment to the underrep-
resented class becomes more likely.
If the weights are weakened on this imbalance to 0.05 for
the stratum, 0.02 for both the stratiﬁcation variables and
0.01 for overall, we get a weighted imbalance of:









× −1 = −0.11
Taking the logit function of this weighted diﬀerence leads
to the probability of assigning the participant to treatment
A:
2 × exp(−0.11)
1 + 2 × exp(−0.11) = 0.64
This probability is barely diﬀerent from the probability of
0.66 that would be obtained with simple randomization.
The imbalances seen within this example are not extreme
enough to warrant a huge shift in the calculated probabil-
ity of assigning to treatment A. The weights are used to
control the imbalance. If all the weights in the model are
set to 0 then the algorithm will perform like simple ran-
domization. If all the weights are set to 10 then thismimics
a deterministic randomization with a block size of 2.
Results and discussion
Simulations
The reason for developing this method is its ability to
control imbalance while preventing predictability.
Simulations were run to show the predicted outcome
of a randomization set-up with various sets of weights.
Each of 50 randomly generated participants were sequen-
tially allocated to a trial. This was repeated 1,000 times for
each set of weights. Take the example from the previous
section: a two-group randomization on a 1:1 allocation
ratio with two stratiﬁcation variables, center (X, Y, Z)
and gender (male, female). The sets of weights for each
scenario are given in Table 2.
From Tables 3, 4 and 5 we can see the control that
the algorithm instills. Scenario 1 shows that with the
larger weights in control, there is a high likelihood that
the ﬁnal split of allocations will be close to the required
split (although not guaranteed). Scenario 3 shows that
there is still some control of the allocations in that the
worst split obtained is of the order 20–30, which is bet-
ter than had there been no control as seen with the simple
randomization.
Table 2 Weights for each simulation scenario
Scenario Control Overall Center Gender Stratum
1 strong 1 2 2 5
2 medium 0.1 0.2 0.2 0.5
3 weak 0.01 0.02 0.02 0.05
4 simple randomization 0 0 0 0
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Table 3 Overall allocated splits of the 50 participants to
the two-group trial over the 1,000 simulations
Group A Group B Strong Medium Weak Simple
randomization
< 20 > 30 60
20 30 1 55
21 29 3 49
22 28 39 72
23 27 14 113 97
24 26 128 231 205 112
25 25 737 511 249 106
26 24 135 230 234 105
27 23 14 116 96
28 22 38 77
29 21 2 64
30 20 41
> 30 < 20 66
Tables 6 and 7 indicate the levels of predictability of the
allocation sequences. In the strong control scenario we
can see from Table 7 that 68% of the probability bound-
aries calculated are either above 0.90 or below 0.10. This
indicates that this implementation of the algorithm is too
Table 4 Imbalances seen within gender across the 1,000
simulations





−4 3 110 105
−3 44 165 157
−2 74 214 217 126
−1 506 466 278 172
0 829 543 304 167
1 514 467 264 154
2 77 222 231 169
3 39 184 151





aA diﬀerence of −7 indicates that there were seven more participants allocated
to treatment group B than treatment group A.
Table 5 Imbalances seen within center across the 1,000
simulations






−4 2 145 93
−3 53 243 158
−2 83 300 349 172
−1 720 706 423 199
0 1372 892 480 201
1 750 684 442 265
2 75 309 347 212
3 47 253 217






aA diﬀerence of −7 indicates that there were seven more participants
allocated to treatment group B than treatment group A.
predictable. It is likely once there is an imbalance that the
boundaries will swing widely to rectify the imbalance as
soon as possible. The weak control scenario demonstrates
that the resulting allocations are limited, that is while the
worst split you can expect to achieve is 20–30 (instead
of the desired 25–25) this comes at no cost in the pre-
dictability of the method and only a tiny percentage of
the boundaries calculated were actually less then 0.10 or
greater than 0.90. So even if the assessors knew all the
weights and the current allocations and how to calculate
the boundaries they would still not have a deﬁnite knowl-
edge of the treatment group that the next participant
would be allocated to.
An additional advantage of running simulations like
these is that various time points may be looked at in rela-
tion to the randomization. Table 8 shows the expected
result once 12 participants have been randomized to the
trial. This information gives us a quick checkpoint to
see where the randomization result is in relation to the
expected result in real time.
Simulations with results like those given in Tables 3 to
8 allow the randomization to be thoroughly tested before
the start of recruitment and will give an indication of the
outcome that can be expected in advance. This allows
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Table 6 Maximum sequences of same group allocations
Maximum repeated Strong Medium Weak Simple
allocationa randomization
2 18
3 509 119 29 22
4 426 445 247 155
5 46 312 307 281
6 1 103 231 215
7 18 118 146








aIn Scenario 1, 1/1000 runs had a maximum run of 6. That is, six allocations to the
same treatment group in a row.
real-time tracking of how the method is performing in
relation to its expected ranges.
Two-group randomization in practice: FolATED equal
allocation
FolATED was a HTA-funded multi-centered randomized
placebo-controlled trial investigating whether folic acid
(folate) would improve patients’ responses to antidepres-
sant treatment and reduce the symptoms of moderate to
severe depression [4].
Randomization for the trial was performed remotely by
NWORTH using this technique. Participants were to be
stratiﬁed by: (1) center (Swansea, Wrexham or Bangor);
(2) gender (male/female); (3) patient type (new/continuing
(that is having taken the same daily antidepressant for
at least two months with a stable dose in the therapeu-
tic range (BNF) for at least one month)); (4) the type of
antidepressant prescribed (SSRI/other) and (5) whether or
not they have ever received counseling for depression.
For system purposes, stratiﬁcation variables 3 and 5
were combined from two binary stratiﬁcation variables
into one stratiﬁcation variable with four levels called
patient type (new/counseling, new/no counseling, con-
tinuing/counseling and continuing/no counseling). It was
intended to randomize 549 participants for the trial.
From the simulations the weights for the trial were cho-
sen to be: overall = 0.02, center = 0.04, gender = 0.04,
patient type = 0.02, type of antidepressant = 0.02 and
stratum = 0.05. The most likely split given this level
Table 7 Probability distributions of the calculated
boundariesa
Interval Strongb,c Mediumb Weakb
[0, 0.05] 17184 2275 6
34% 5% <1%
(0.05, 0.15] 2506 3394 233
5% 7% <1%
(0.15, 0.25] 0 4157 1055
0% 8% 2%
(0.25, 0.35] 2795 4367 2963
6% 9% 6%
(0.35, 0.45] 0 5921 8372
0% 12% 17%
(0.45, 0.55] 5121 10181 25155
10% 20% 50%
(0.55, 0.65] 0 5897 8112
0% 12% 16%
(0.65, 0.75] 2887 4188 2852
6% 8% 6%
(0.75, 0.85] 0 4125 1015
0% 8% 2%
(0.85, 0.95] 2363 3365 231
5% 7% <1%
(0.95, 1] 17144 2130 6
34% 4% <1%
aSimple randomization has not been included here as the boundary is always at
0.5.
bThe frequency (%) of the calculated boundaries that occured in each of the
intervals is shown.
cFor the strong control scenario all boundaries in the (0.45, 0.55] interval are 0.5.
Table 8 Allocation splits after 12 of the 50 participants
expected have been randomized for each scenario
Group A Group B Strong Medium Weak Simple
randomization
1 11 1
2 10 3 15
3 9 16 54
4 8 9 98 106
5 7 124 225 248 201
6 6 746 512 264 226
7 5 130 239 245 201
8 4 15 105 115
9 3 19 55
10 2 2 22
11 1 3
12 0 1
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of weighting was 274:275 (or 275:274) with a probabil-
ity of 0.64 of this occurring. The most extreme overall
split that should have been seen was 272:277 (or 277:272)
with a probability of 0.05. An exact balance within the
various stratiﬁcation variables should be seen with a prob-
ability of between 0.37 to 0.45. It is likely that the bal-
ance within the stratiﬁcation variables would not have
been far beyond the exact balance given the weights
chosen.
The number of participants recruited to the trial
was 440. Overall 223 participants were allocated to
the folate treatment and 217 to the placebo treatment.
The folate:placebo allocations by center were: Bangor
(110:113), Swansea (56:51), Wrexham (57:53); by gen-
der were female (144:136), male (79:81); by patient type
were new (56:52), continuing (167:165); by antidepressant
were SSRI (157:145), other (66:72) and by counseling were
received (101:97), no (122:120).
Two-group randomization in practice: EPIC unequal
allocation
EPIC was a pragmatic randomized control trial, designed
to evaluate an individually tailored, age-appropriate infor-
mation pack to support decision-making and self-care
relating to insulin management and electronic glucose
monitoring for children/young people aged 6–18 years
with type 1 diabetes, compared with available resources
in routine clinical practice [5]. The target sample size
was 252 children/young people with type 1 diabetes. A
2:1 randomization strategy was employed and the inten-
tion was to randomize 168 children/young people into the
intervention arm and 84 children/young people into the
no intervention arm, stratiﬁed by age (6–10 years, 11–15
years and 16–18 years), gender and length of time since
diagnosis (<2 years and ≥2 years).
Simulations were run and it was decided that the
parameter set should be: overall = 0.05, gender = 0.05,
age = 0.05, diagnosis = 0.05, center = 0.1 and stra-
tum = 0.2. These simulations indicated that the proba-
bility of an overall split of 168:84 would be 0.41, with the
worst possible splits being 165:87 (probability 0.01) and
170:82 (probability 0.13).
The EPIC trial actually randomized 339 participants in
total. This was balanced overall as 225:114. If the simula-
tions had been run for 339 participants with the selected
weights the probability of getting this overall split would
have been 0.33. Within gender the balance achieved for
male and female was (105:55) and (120:59), respectively.
Within the age groups the balance achieved for 6–10
years, 11–15 years and 16–18 years was (79:40), (104:53)
and (42:21), respectively. Within diagnosis the balance
achieved for less than 2 years and 2 years or more was
(48:26) and (177:88), respectively.
Three-group randomization in practice: SWAD
SWAD (staying well after depression) was a multi-center,
randomized controlled trial [6]. Participants were ran-
domized between mindfulness-based cognitive therapy
(MBCT) in addition to treatment as usual (TAU), cogni-
tive psycho-education (CPE) in addition to TAU, and TAU
alone in a ratio of 2:2:1. The participants were stratiﬁed
by: (a) research center (Oxford or Bangor), (b) cohort (six
cohorts of recruitment), (c) history of suicidality (none,
ideation or suicidal attempt) and (d) whether or not they
were taking antidepressants in the 7 days before their ﬁrst
assessment (AD use). Randomization was undertaken by
email to the remote randomization center at NWORTH.
For validation the randomization email also includes addi-
tional information including the participant’s date of birth,
gender and date of assessment. The target sample size was
375 randomized participants.
Simulations were run to select the ideal set of weights to
use for the randomization system. It was decided to use:
overall = 0.05, center = 0.1, cohort = 0.1, antidepres-
sant use = 0.05, suicidality = 0.05 and stratum = 0.25.
The exact split of 150:150:75 has a probability of 0.17.
However, acceptable results of 149:150:76, 149:151:75,
150:149:76 combined with the exact split have a probabil-
ity of 0.55. No overall split seen in the simulation was too
far away from the intended 2:2:1 ratio.
The SWAD trial actually randomized 276 participants.
Overall this was split 110:110:56. From the simulations
this was expected with a probability of 0.18. Within center
the achieved balance was Bangor (49:49:25) and Oxford
(61:61:31). Within antidepressant use the achieved bal-
ance was no AD use (62:60:32) and yes AD use (48:50:24).
Within suicidality the achieved balance was no suicidality
(20:21:12), suicidal ideation (56:55:28) and suicide attempt
(34:34:16).
Conclusions
The randomization method introduced here may appear
complex but allows the control of imbalance at various
levels of the trial without compromising the predictability.
This ultimately allows balanced groups with no increased
risk of subversion introduced at any level. The system
has been implemented successfully as a web-based ran-
domization system. This system allows approved users
to log in and securely enter their data resulting in an
instant randomization result. This result can either be
blinded or open dependent on the requirements of the
trial. A generic system can be implemented allowing any
of the situations described earlier. Validation of the data
input should also ensure that the data entered is cor-
rect – no participant can be randomized twice and there
will be no out-of-range dates of birth. This method has
been shown to work in a number of fully randomized
trials.
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